Related Experiment Videos
Validation of removal of human retroviruses
1Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD.
Developments in Biological Standardization
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Susceptibility of the Sf9 insect cell line to infection with adventitious viruses.
Biologicals : journal of the International Association of Biological Standardization·1994
Regulatory issues relating to the use of recombinant vectors in production of human vaccines.
Developments in biological standardization·1994
Conformation-dependent recognition of baculovirus-expressed Epstein-Barr virus gp350 by a panel of monoclonal antibodies.
The Journal of general virology·1993
St Louis encephalitis virus establishes a productive, cytopathic and persistent infection of Sf9 cells.
The Journal of general virology·1993
Characterization of a DNA binding domain in the C-terminus of HIV-1 integrase by deletion mutagenesis.
Nucleic acids research·1993
International challenges and public policy issues.
Developments in biological standardization·2000
Standardisation and licensing of combination vaccines based on DTP.
Developments in biological standardization·2000
The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics.
Developments in biological standardization·2000
Cytokine and growth factor standardization: the need for research to answer modern issues.
Developments in biological standardization·2000
Alternatives to the use of animals for bacterial toxins and antitoxins.
Developments in biological standardization·2000
Cell substrates: lessons learned and challenges remaining.
Developments in biological standardization·2000